British Fertility Society Statement on retinoblastoma in IVF babies
January 2003
The British Fertility Society1 (BFS) understands the concerns of
patients regarding a recent report2 from the Netherlands that has
linked assisted conception treatment to an increased risk of developing
the very rare cancer, retinoblastoma. The BFS is committed to carefully
monitoring the consequences of treatments that we provide and will
continue to review such reports carefully.
The report acknowledges that these are isolated cases and that
there is no confirmed evidence linking IVF treatment and retinoblastoma,
a rare condition that affects 1 in 17000 children. The chance of
any child – whether conceived naturally or through IVF –
developing cancer before the age of 15 years is 1 in 600. About
80% of these cases are curable. We do not have any evidence that
the overall risk of cancer is increased after assisted conception
treatment.
The BFS is committed to providing a safe treatment for couples
that are unable to have a family and will continue to work with
researchers to ensure that we achieve this aim. Dr Alison Murdoch,
chair of the BFS, comments: ‘The number of children born after
IVF will continue to increase as the treatment and its availability
improves. Sadly, it is inevitable that some of these children will
develop the same problems suffered by other children who were conceived
naturally. Whilst it is vital that we are aware of the potential
risks of IVF, patients who have children as a result of IVF can
be reassured that this report is an isolated finding. Parents should
remain confident that their children need no tests for this condition.’
1The British Fertility Society is a national multidisciplinary
organisation representing professionals practising in the field
of reproductive medicine.
2Report in the Lancet.
For more information: please contact the British Fertility Society press office
|